Active ingredientDeflazacortCat. No. P-D034-001CAS 14484-47-0Family · Pharmaceutical analytical standards
Deflazacort
A glucocorticoid derived from prednisolone, patented in 1969 and in use since 1985 as an anti-inflammatory and immunosuppressant; in the United States it was approved in 2017 for Duchenne muscular dystrophy. This family brings together the active ingredient and other impurities.
Did you know?Duchenne muscular dystrophy is named after the French neurologist Guillaume Duchenne de Boulogne, who also gave his name to the "Duchenne smile", the genuine smile that also engages the muscles around the eyes.
Go to the active ingredient →Active ingredientDeflazacortCat. No. P-D034-001CAS 14484-47-0
Impurity1,2-Dihydro-deflazacortCat. No. P-D034-002CAS 23557-89-3
Impurity11-epi DeflazacortCat. No. P-D034-003
Impurity21-Deacetoxy DeflazacortCat. No. P-D034-004CAS 13649-88-2
Impurity21-Desacetyl 21-Iodomethoxy DeflazacortCat. No. P-D034-005
Impurity21-Formate DeflazacortCat. No. P-D034-006
Impurity21-Hydroxy DeflazacortCat. No. P-D034-007CAS 13649-57-5
Impurity6-alpha-Hydroxy DeflazacortCat. No. P-D034-008CAS 1262053-48-4
Impurity6-alpha-Hydroxy-21-desacetyl DeflazacortCat. No. P-D034-009CAS 87539-45-5
Impurity6beta-Hydroxy-21-desacetyl deflazacortCat. No. P-D034-010CAS 72099-45-7
ImpurityDeflazacort Impurity 1Cat. No. P-D034-011
ImpurityDeflazacort Impurity 2Cat. No. P-D034-015
ImpurityDeflazacort Impurity 3Cat. No. P-D034-016CAS 13649-84-8
ImpurityDeflazacort Impurity 4Cat. No. P-D034-017CAS 1425664-43-2
ImpurityDeflazacort Impurity 5Cat. No. P-D034-018
ImpurityDeflazacort Impurity 6Cat. No. P-D034-019
ImpurityDeflazacort Impurity CCat. No. P-D034-020CAS 710951-92-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.